Knowing your patient’s hereditary cancer risk is critical when it comes to making treatment decisions. Blending both their genetic test status and family history of cancer, the Myriad myRisk® hereditary cancer panel represents the next generation of hereditary cancer risk testing. Myriad myRisk is here to help you determine the right treatment for your patients with a report including comprehensive results and a guideline-based Medical Management Tool.

Offer Accurate and Comprehensive Risk Assessment
in Your Practice with myRisk and riskScore


The Myriad myRisk® Hereditary Cancer multi-gene panel analyzes risk for 8 cancers of focus to determine if your patient has a germline genetic mutation associated with an increased cancer risk. Receive test results in 14 days or less.

Learn More

riskScore® is a clinically validated tool which uses genetic markers and clinical risk factors to predict a 5-year and remaining lifetime risk of developing breast cancer.*

Learn More

Faster Results for Patients with
Pancreatic Cancer to Inform Treatment


BRCA1/2, PALB2 and 8 other genes reported in 5-12 calendar days**†
Full Myriad myRisk report in 14 calendar days or less

Learn More